Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Blend Labs, Inc.BLND · Entity 5752 | Director · HEAD OF BLEND | October 12, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Blend Labs, Inc.
Report date October 12, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 7,778,468 |
Reported balance
After 2026-10-12 transaction · row 1
1 source rowRow 1 · 2026-10-12 · Sale · Disposed 25,098 · Balance 7,778,468 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2026. F2: This sale price represents the weighted average sale price of the shares sold ranging from $0.954 to $1.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2026.
F2: This sale price represents the weighted average sale price of the shares sold ranging from $0.954 to $1.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2023 Filed Nov 22, 2023 23:05 UTC | Blend Labs, Inc. BLND · Entity 5752 | Exercise / conversionRestricted Stock Units · Derivative | 375,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-056533 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,625,000 Underlying: Class A Common Stock · 375,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. F3 · derivative.exercise_date: The RSUs will vest in equal quarterly increments over a four year period, subject to the Reporting Person continuing to be a Service Provider through each such date. F3 · derivative.expiration_date: The RSUs will vest in equal quarterly increments over a four year period, subject to the Reporting Person continuing to be a Service Provider through each such date. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 23:05 UTC | Blend Labs, Inc. BLND · Entity 5752 | Tax withholdingClass A Common Stock | 154,674 | $1.26 | $194,889.24 |
DisclosureSEC source: 0001209191-23-056533 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,326 F2 · kind: Shares were withheld to cover tax obligations in connection with the vesting of RSUs. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 23:05 UTC | Blend Labs, Inc. BLND · Entity 5752 | Exercise / conversionClass A Common Stock | 375,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-056533 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 22:50 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 111,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051696 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,289,290 Underlying: Class A Common Stock · 111,940 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On September 29, 2023, the Reporting Person sold the shares pursuant to a Rule 10b5-1 trading plan and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F5 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 22:50 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 111,940 | $1.37 | $152,842.88 |
DisclosureSEC source: 0001209191-23-051696 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $1.32 to $1.44 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 22:50 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 111,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051696 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,940 Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 20:30 UTC | Blend Labs, Inc. BLND · Entity 5752 | GrantRestricted Stock Units · Derivative | 6,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-047322 · doc4.xml · derivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000,000 Underlying: Class A Common Stock · 6,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly increments over a four year period, subject to the Reporting Person continuing to be a Service Provider through each such date. F2 · derivative.expiration_date: The RSUs will vest in equal quarterly increments over a four year period, subject to the Reporting Person continuing to be a Service Provider through each such date. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 114,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044182 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,401,230 Underlying: Class A Common Stock · 114,504 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On July 31, 2023, the Reporting Person sold the shares pursuant to a Rule 10b5-1 trading plan and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F5 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 114,504 | $1.32 | $151,213.98 |
DisclosureSEC source: 0001209191-23-044182 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $1.28 to $1.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 114,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044182 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,504 Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:16 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 153,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041014 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,515,734 Underlying: Class A Common Stock · 153,531 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On June 30, 2023, the Reporting Person sold the shares pursuant to a Rule 10b5-1 trading plan and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F5 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:16 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 153,531 | $0.96 | $147,343.70 |
DisclosureSEC source: 0001209191-23-041014 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $0.94 to $1.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:16 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 153,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041014 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,531 Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:08 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 151,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033669 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,669,265 Underlying: Class A Common Stock · 151,316 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On May 31, 2023, the Reporting Person sold the shares pursuant to a Rule 10b5-1 trading plan and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F5 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:08 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 151,316 | $0.95 | $144,461.39 |
DisclosureSEC source: 0001209191-23-033669 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $0.9035 to $0.9999 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:08 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 151,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033669 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,316 Read SEC document |
| April 28, 2023 Filed May 2, 2023 22:18 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 230,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026690 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,820,581 Underlying: Class A Common Stock · 230,770 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On April 28, 2023, the Reporting Person sold the shares pursuant to a Rule 10b5-1 trading plan and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F5 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| April 28, 2023 Filed May 2, 2023 22:18 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 230,770 | $0.61 | $140,308.16 |
DisclosureSEC source: 0001209191-23-026690 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $0.5801 to $0.6615 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 28, 2023 Filed May 2, 2023 22:18 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 230,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026690 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,770 Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:07 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 169,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021857 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,051,351 Underlying: Class A Common Stock · 169,242 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On March 29, 2023, the Reporting Person sold the shares pursuant to a Rule 10b5-1 trading plan and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F5 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:07 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 169,242 | $0.94 | $158,765.92 |
DisclosureSEC source: 0001209191-23-021857 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $0.85 to $1.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:07 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 169,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021857 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,242 Read SEC document |
| December 12, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 766,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · derivative · entry 9 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,220,593 Underlying: Class A Common Stock · 766,092 shares Expires not disclosed F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F8 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On December 12, 2022, the Reporting Person sold the shares and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F6 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| December 12, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 766,092 | $1.26 | $963,820.35 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · nonDerivative · entry 6 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $1.25 to $1.3175 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 12, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 766,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · nonDerivative · entry 5 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766,092 Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 175,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · derivative · entry 8 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,986,685 Underlying: Class A Common Stock · 175,772 shares Expires not disclosed F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F7 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On December 9, 2022, the Reporting Person sold the shares and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F6 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 175,772 | $1.24 | $218,607.64 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · nonDerivative · entry 4 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $1.23 to $1.285 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 175,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · nonDerivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,772 Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 970,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · derivative · entry 7 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,162,457 Underlying: Class A Common Stock · 970,874 shares Expires not disclosed F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F5 · shares: All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On December 8, 2022, the Reporting Person sold the shares and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F6 · balance_after: The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | SaleClass A Common Stock | 970,874 | $1.11 | $1,077,670.14 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $1.09 to $1.155 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 23:54 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 970,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-060772 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970,874 Read SEC document |
| December 28, 2021 Filed Jun 2, 2022 20:16 UTC | Blend Labs, Inc. BLND · Entity 5752 | GiftClass A Common Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033518 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 20, 2021 Filed Dec 23, 2021 01:30 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071001 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,133,331 Underlying: Class A Common Stock · 250,000 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F1 · kind: Shares of Class B Common Stock were exchanged at a 1:1 ratio for shares of Class A Common Stock at the election of the Reporting Person. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Read SEC document |
| December 20, 2021 Filed Dec 23, 2021 01:30 UTC | Blend Labs, Inc. BLND · Entity 5752 | GiftClass B Common Stock · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071001 · doc4.xml · derivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,383,331 Underlying: Class A Common Stock · 500,000 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Read SEC document |
| December 20, 2021 Filed Dec 23, 2021 01:30 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071001 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Head of Blend 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 F1 · kind: Shares of Class B Common Stock were exchanged at a 1:1 ratio for shares of Class A Common Stock at the election of the Reporting Person. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 21:39 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass B Common Stock · Derivative | 6,312,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-047813 · doc4.xml · derivative · entry 4 Ghamsari Nima · CIK 0001870974 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,883,331 Underlying: Class A Common Stock · 6,312,498 shares Expires not disclosed F2 · derivative.exercise_price: Immediately prior to the closing of the IPO, the Reporting Person's shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock in a transaction previously approved by the Issuer's board of directors. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F2 · kind: Immediately prior to the closing of the IPO, the Reporting Person's shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock in a transaction previously approved by the Issuer's board of directors. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F2 · derivative.exercise_date: Immediately prior to the closing of the IPO, the Reporting Person's shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock in a transaction previously approved by the Issuer's board of directors. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F2 · derivative.expiration_date: Immediately prior to the closing of the IPO, the Reporting Person's shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock in a transaction previously approved by the Issuer's board of directors. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 21:39 UTC | Blend Labs, Inc. BLND · Entity 5752 | ConversionFounders Preferred Stock · Derivative | 345,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-047813 · doc4.xml · derivative · entry 3 Ghamsari Nima · CIK 0001870974 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 345,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Founders Preferred Stock was converted into one share of Class A Common Stock prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO"), and immediately prior to the closing of the IPO, such shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F1 · kind: Each share of Founders Preferred Stock was converted into one share of Class A Common Stock prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO"), and immediately prior to the closing of the IPO, such shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F1 · derivative.exercise_date: Each share of Founders Preferred Stock was converted into one share of Class A Common Stock prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO"), and immediately prior to the closing of the IPO, such shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F1 · derivative.expiration_date: Each share of Founders Preferred Stock was converted into one share of Class A Common Stock prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO"), and immediately prior to the closing of the IPO, such shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 21:39 UTC | Blend Labs, Inc. BLND · Entity 5752 | OtherClass A Common Stock | 6,312,498 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-047813 · doc4.xml · nonDerivative · entry 2 Ghamsari Nima · CIK 0001870974 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Immediately prior to the closing of the IPO, the Reporting Person's shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock in a transaction previously approved by the Issuer's board of directors. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F2 · price: Immediately prior to the closing of the IPO, the Reporting Person's shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock in a transaction previously approved by the Issuer's board of directors. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 21:39 UTC | Blend Labs, Inc. BLND · Entity 5752 | ConversionClass A Common Stock | 345,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-047813 · doc4.xml · nonDerivative · entry 1 Ghamsari Nima · CIK 0001870974 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,312,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Founders Preferred Stock was converted into one share of Class A Common Stock prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO"), and immediately prior to the closing of the IPO, such shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F1 · price: Each share of Founders Preferred Stock was converted into one share of Class A Common Stock prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO"), and immediately prior to the closing of the IPO, such shares of Class A Common Stock were exchanged at a 1:1 ratio for shares of Class B Common Stock. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.